Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorth Atl.smlr Regulatory News (NAS)

Share Price Information for North Atl.smlr (NAS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,920.00
Bid: 3,890.00
Ask: 3,930.00
Change: 10.00 (0.26%)
Spread: 40.00 (1.028%)
Open: 3,950.00
High: 3,950.00
Low: 3,890.00
Prev. Close: 3,910.00
NAS Live PriceLast checked at -
North Atlantic Smaller Companies is an Investment Trust

To provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

17 Dec 2013 09:08

RNS Number : 7238V
North Atlantic Smlr Co Inv Tst PLC
17 December 2013
 



NORTH ATLANTIC SMALLER COMPANIES INVESTMENT TRUST PLC

 

INTERIM MANAGEMENT STATEMENT FOR THE PERIOD ENDED 31 OCTOBER 2013

 

To the members of North Atlantic Smaller Companies Investment Trust PLC

This interim management statement has been produced solely to provide additional information to shareholders as a body in accordance with the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.

 

This interim management statement relates to the period from 1 August 2013 to 31 October 2013, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified.

 

Investment Objective

The objective of North Atlantic Smaller Companies Investment Trust PLC ("the Company") is to provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

 

Financial Highlights

Cumulative performance

As at

31 October 2013

3 months %

6 months %

1 year 

%

3 years %

5 years %

Diluted NAV*

1,864p 

2.2 

8.4 

25.7

36.7 

84.9 

Mid-market price

1,588p 

6.4 

13.8 

38.0

52.0 

146.2 

Discount to diluted NAV *

14.8% 

Standard & Poor's 500 Composite Index **

1,095.1 

(1.2)

6.5 

25.1

48.4 

81.7 

Russell 2000 **

685.9 

(0.2)

12.4 

35.1

56.4 

105.1 

FTSE All-Share Index

3,585.3 

2.2 

5.8 

18.6

22.1 

64.2 

US Dollar/Sterling exchange rate

1.6066 

(6.0)

(3.2)

0.3

(0.5)

0.6 

 

* Following the conversion of the Loan Notes the performance is shown on the diluted NAV, excluding retained revenue for the period, only. The Board considers that this accurately reflects the underlying performance of the Company

** Sterling adjusted.

 

 

Material Events and Transactions during the Period

 

During the period under review, the Company's holdings in Bionostics and Orthoproducts were sold at a good uplift to the year-end valuation and at a significant premium to cost. As a result, the Company now has cash or near cash balances of circa £80 million.

 

 

Transactions in Own Shares

 

On 26 September 2013, 1,450 Ordinary shares were bought back for cancellation, at a total cost to the Company of £22,000.

 

Since 31 October 2013, a further 13,483 Ordinary shares were bought back for cancellation, in two tranches, at the beginning of December 2013, at a total cost of £208,000.

 

Following these purchases the Company's issued share capital consists of 15,897,501 Ordinary shares.

 

 

 

TEN LARGEST INVESTMENTS AT 31 OCTOBER 2013

Gleeson (MJ) Group

UK Listed

11.5

US Treasury Bills

US Treasury Bills

18.8

Oryx International Growth Fund Limited *

UK Listed

11.5

Trident Private Equity Fund III LLP

UK Unquoted

8.3

Hampton Investment Properties Limited

UK Unquoted

5.2

Bioquell

UK Listed

4.7

Guinness Peat Group **

UK Listed

4.5

Celsis AG

US Unquoted

3.5

AssetCo PLC

UK Listed

2.8

Goals Soccer Centres

UK Listed

2.6

% of total portfolio

73.4

 

* incorporated in Guernsey

** incorporated in New Zealand

 

SECTOR ANALYSIS OF INVESTMENTS AT FAIR VALUE AS AT 31 OCTOBER 2013

 

United 

United 

Total 

States 

Kingdom 

Europe 

Investment Companies

20.5

20.5

Treasury Bills

18.8

18.8

Construction & Materials

11.5

11.5

Real Estate

0.2

7.6

0.4

8.2

Support Services

1.0

5.1

6.1

Industrial Engineering

5.1

5.1

Health Care, Equipment & Services

0.2

4.7

4.9

Financial Services

4.5

4.5

Travel & Leisure

3.5

3.5

Media

3.2

3.2

Banks

3.1

3.1

Escrows

1.7

0.4

2.1

Oil & Gas Producers

1.2

0.8

2.0

General Retailers

1.7

1.7

Technology Hardware & Equipment

1.5

1.5

Food Producers

1.3

1.3

Industrial Transportation

1.3

1.3

Business Services

0.7

0.7

 

The financial information for the period ended 31 October 2013 contained within this Interim Management Statement has not been audited.

 

 

By order of the Board

 

 

Bonita Guntrip

Company Secretary

17 December 2013

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGMMMZLNDGFZG
Date   Source Headline
28th Sep 200911:04 amRNSHolding(s) in Company
24th Sep 200911:04 amRNSHolding(s) in Company
24th Sep 20097:00 amRNSClosing of the Offer
10th Sep 20094:22 pmRNSHolding(s) in Company
10th Sep 20094:02 pmRNSHalf Yearly Report
9th Sep 20094:26 pmRNSCancellation of Listing
9th Sep 200912:56 pmRNSOffer Update
8th Sep 200910:18 amRNSNet Asset Value(s)
1st Sep 200910:06 amRNSRule 8.1- Celsis International Plc - Amendment
1st Sep 20097:00 amRNSRule 8.1 (Celsis International Plc)
28th Aug 20097:00 amRNSRule 8.1- Celsis International
25th Aug 20097:00 amRNSOffer and Trading Update
19th Aug 200910:35 amRNSHolding(s) in Company
13th Aug 20094:51 pmRNSTransaction in Own Shares
13th Aug 20093:24 pmRNSTransactions in a Close Period
12th Aug 20097:00 amRNSRule 8.1- Celsis International plc
10th Aug 20097:00 amRNSOffer Update
7th Aug 200912:20 pmRNSNet Asset Value(s)
5th Aug 200910:04 amRNSHolding(s) in Company
3rd Aug 20097:00 amRNSre: Offer
30th Jul 20099:12 amRNSHolding(s) in Company
23rd Jul 20093:45 pmRNSResult of Meeting
23rd Jul 20099:18 amRNSHolding(s) in Company
22nd Jul 20099:51 amRNSTotal Voting Rights
16th Jul 20094:21 pmRNSAdditional Listing
15th Jul 20093:26 pmRNSDirector/PDMR Shareholding
13th Jul 200911:24 amRNSNotice of Loan Stock Meeting
7th Jul 200911:46 amRNSNet Asset Value(s)
1st Jul 20099:38 amRNSResult of Meeting
30th Jun 20093:11 pmRNSResult of AGM
15th Jun 20091:57 pmRNSInterim Management Statement
11th Jun 20094:14 pmRNSHolding(s) in Company
9th Jun 20095:27 pmRNSNet Asset Value(s)
4th Jun 20099:13 amRNSHolding(s) in Company
2nd Jun 20094:17 pmRNSAnnual Information Update
1st Jun 20093:46 pmRNSHolding(s) in Company
1st Jun 200912:28 pmRNSAnnual Financial Report
26th May 20091:52 pmRNSDirector/PDMR Shareholding
26th May 20099:28 amRNSDirector/PDMR Shareholding
22nd May 20094:42 pmRNSHolding(s) in Company
21st May 20097:00 amRNSAnnual Financial Report
13th May 20094:39 pmRNSNet Asset Value(s)
11th May 20094:54 pmRNSFinal Results
5th May 20093:33 pmRNSHolding(s) in Company
20th Apr 200910:03 amRNSHolding(s) in Company
7th Apr 20094:08 pmRNSHolding(s) in Company
3rd Apr 200911:56 amRNSRule 8.1- GNE Group Plc
12th Mar 20093:34 pmRNSHolding(s) in Company
11th Mar 20097:00 amRNSHolding(s) in Company
9th Mar 20093:50 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.